Department of Thoracic Surgery, West China Hospital, Sichuan University, No. 37, Guoxue Alley, Chengdu, Sichuan, 610041, People's Republic of China.
Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Sichuan University, Chengdu, China.
Ann Surg Oncol. 2020 Oct;27(11):4384-4393. doi: 10.1245/s10434-020-08805-y. Epub 2020 Jul 8.
The purpose of this study was to evaluate the short- and long-term outcomes of video-assisted thoracoscopic surgery (VATS) versus open thoracotomy bronchial sleeve lobectomy (BSL) for patients with central lung cancer.
This is a retrospective cohort study. Perioperative outcomes and long-term survival of patients who underwent VATS versus open thoracotomy BSL for central lung cancer from June 2010 and June 2018 in the Western China Lung Cancer Database were compared using propensity score matching (PSM) between the two surgical approaches.
The retrospective study included 187 patients who divided into VATS group (n = 44) and open group (n = 143) according to surgical approach, and PSM resulted in 43 patients in each group, which were well matched by 11 potential prognostic factors. The VATS group was associated with lower overall incidence of postoperative complications (20.3% vs. 30.2%, P = 0.029), less postoperative drainage (875 ml [250-3960] vs. 1280 ml [100-4890], P = 0.039). The 5-year overall survival (OS) and disease-free survival (DFS) were comparable between the VATS and open groups (55.9% vs. 65.2% P = 0.836 and 54.1% vs. 60.2% P = 0.391, respectively) after matching. Multivariable adjusted analysis demonstrated that the surgical approach was not an independent favorable prognostic factor for OS (hazard ratio [HR] = 0.922; 95% confidence interval [CI], 0.427-1.993; P = 0.836) but just the pTNM stage (HR = 2.003; 95% CI 1.187-3.382; P = 0.009).
VATS BSL may achieve equivalent long-term outcomes for central lung cancer patients when comparing with open thoracotomy. Although slightly longer duration of surgery, VATS approach may be a feasible option for lung cancer patients requiring BSL.
本研究旨在评估电视辅助胸腔镜手术(VATS)与开胸支气管袖状切除术(BSL)治疗中央型肺癌患者的短期和长期疗效。
这是一项回顾性队列研究。通过倾向评分匹配(PSM)比较 2010 年 6 月至 2018 年 6 月在中国西部肺癌数据库中接受 VATS 与开胸手术的中央型肺癌患者的围手术期结局和长期生存情况。
回顾性研究纳入了 187 例患者,根据手术方式分为 VATS 组(n=44)和开胸组(n=143),通过 11 个潜在预后因素进行 PSM 后,每组各有 43 例患者,匹配效果良好。VATS 组术后总体并发症发生率较低(20.3% vs. 30.2%,P=0.029),术后引流更少(875ml[250-3960] vs. 1280ml[100-4890],P=0.039)。VATS 组和开胸组 5 年总生存率(OS)和无病生存率(DFS)相当(55.9% vs. 65.2%,P=0.836;54.1% vs. 60.2%,P=0.391)。多变量调整分析表明,手术方式不是 OS 的独立预后因素(风险比[HR]=0.922;95%置信区间[CI],0.427-1.993;P=0.836),仅 pTNM 分期是独立预后因素(HR=2.003;95%CI 1.187-3.382;P=0.009)。
与开胸手术相比,VATS BSL 可能为中央型肺癌患者带来等效的长期疗效。虽然手术时间稍长,但 VATS 方法可能是需要 BSL 的肺癌患者的可行选择。